What is NOT typically included in the triple drug immunosuppressive therapy for organ transplant procedures?

In the context of triple drug immunosuppressive therapy for organ transplants, it is essential to understand the roles and common usage of the respective drugs. The standard regimen typically includes a calcineurin inhibitor (such as Cyclosporine), a corticosteroid (such as Prednisone), and an antiproliferative agent (like Azathioprine).

Rapamycin, while an important immunosuppressant, is not commonly part of the standard triple regimen. Instead, it is often utilized in specific cases or as an alternative to one of the other drugs in the regimen, but it does not routinely form a cornerstone of the triple therapy as seen with the other medications listed. This distinct use is why Rapamycin is identified as the drug that is NOT typically included in the triple drug regimen for organ transplantation.

Understanding these nuances is crucial when considering the multi-faceted approach required for successful organ transplantation, which aims to balance effective immunosuppression with minimizing potential side effects.